The universal nine-amino-acid transactivation domains (9aaTADs) have been identified in numerous transcription activators. Here, we identified the conserved 9aaTAD motif in all nine members of the specificity protein (SP) family. Previously, the Sp1 transcription factor has been defined as a glutamine-rich activator. We showed by amino acid substitutions that the glutamine residues are completely dispensable for 9aaTAD function and are not conserved in the SP family. We described the origin and evolutionary history of 9aaTADs. The 9aaTADs of the ancestral Sp2 gene became inactivated in early chordates. We next discovered that an accumulation of valines in 9aaTADs inactivated their transactivation function and enabled their strict conservation during evolution. Subsequently, in chordates, Sp2 has duplicated and created new paralogs, Sp1, Sp3, and Sp4 (the SP1-4 clade). During chordate evolution, the dormancy of the Sp2 activation domain lasted over 100 million years. The dormant but still intact ancestral Sp2 activation domains allowed diversification of the SP1-4 clade into activators and repressors. By valine substitution in the 9aaTADs, Sp1 and Sp3 regained their original activator function found in ancestral lower metazoan sea sponges. Therefore, the vertebrate SP1-4 clade could include both repressors and activators. Furthermore, we identified secondary 9aaTADs in Sp2 introns present from fish to primates, including humans. In the gibbon genome, introns containing 9aaTADs were used as exons, which turned the Sp2 gene into an activator. Similarly, we identified introns containing 9aaTADs used conditionally as exons in the (SP family-unrelated) transcription factor SREBP1, suggesting that the intron-9aaTAD reservoir is a general phenomenon.

CEITEC Masaryk University Kamenice 753 5 Pavilion A35 Brno 62 500 Czech Republic

Department of Pathological Physiology Faculty of Medicine Gamma Delta T Cell Laboratory Masaryk University Brno Kamenice 5 Brno 625 00 Czech Republic

Department of Pathological Physiology Faculty of Medicine Laboratory of Cancer Biology and Genetics Masaryk University Brno Kamenice 5 Brno 625 00 Czech Republic

Zobrazit více v PubMed

Teufel DP, Freund SM, Bycroft M, Fersht AR. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci USA. 2007;104:7009–7014. doi: 10.1073/pnas.0702010104. PubMed DOI PMC

Gamper AM, Roeder RG. Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage. Mol Cell Biol. 2008;28:2517–2527. doi: 10.1128/MCB.01461-07. PubMed DOI PMC

Feng H, Jenkins LMM, Durell SR, et al. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure. 2009;17:202–210. doi: 10.1016/j.str.2008.12.009. PubMed DOI PMC

Ferreon JC, Lee CW, Arai M, et al. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc Natl Acad Sci USA. 2009;106:6591–6596. doi: 10.1073/pnas.0811023106. PubMed DOI PMC

Jenkins LMM, Yamaguchi H, Hayashi R, et al. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry. 2009;48:1244–1255. doi: 10.1021/bi801716h. PubMed DOI PMC

Thakur JK, Arthanari H, Yang F, et al. Mediator subunit Gal11p/MED15 is required for fatty acid-dependent gene activation by yeast transcription factor Oaf1p. J Biol Chem. 2009;284:4422–4428. doi: 10.1074/jbc.M808263200. PubMed DOI PMC

Choi Y, Asada S, Uesugi M. Divergent hTAFII31-binding motifs hidden in activation domains. J Biol Chem. 2000;275:15912–15916. doi: 10.1074/jbc.275.21.15912. PubMed DOI

Uesugi M, Verdine GL. The alpha-helical FXXPhiPhi motif in p53: tAF interaction and discrimination by MDM2. Proc Natl Acad Sci USA. 1999;96:14801–14806. doi: 10.1073/pnas.96.26.14801. PubMed DOI PMC

Piskacek M. 9aaTADs mimic DNA to interact with a pseudo-DNA binding domain KIX of Med15 (molecular chameleons) Nat Proc. 2009 doi: 10.1038/npre.2009.3939.1. DOI

Piskacek M. Common transactivation Motif 9aaTAD recruits multiple general co-activators TAF9, MED15, CBP and p300. Nat Proc. 2009 doi: 10.1038/npre.2009.3488.2. DOI

Di Lello P, Jenkins LMM, Jones TN, et al. Structure of the Tfb1/p53 complex: insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell. 2006;22:731–740. doi: 10.1016/j.molcel.2006.05.007. PubMed DOI

Piskacek S, Gregor M, Nemethova M, et al. Nine-amino-acid transactivation domain: establishment and prediction utilities. Genomics. 2007;89:756–768. doi: 10.1016/j.ygeno.2007.02.003. PubMed DOI

Piskacek M, Vasku A, Hajek R, Knight A. Shared structural features of the 9aaTAD family in complex with CBP. Mol BioSyst. 2015;11:844–851. doi: 10.1039/c4mb00672k. PubMed DOI

Piskacek M, Havelka M, Rezacova M, Knight A. The 9aaTAD transactivation domains: from Gal4 to p53. PLoS One. 2016;11:e0162842. doi: 10.1371/journal.pone.0162842. PubMed DOI PMC

Piskacek M. 9aaTAD prediction result (2006) Nat Proc. 2009;1:1. doi: 10.1038/npre.2009.3984.1. DOI

Sandholzer J, Hoeth M, Piskacek M, et al. A novel 9-amino-acid transactivation domain in the C-terminal part of Sox18. Biochem Biophys Res Commun. 2007;360:370–374. doi: 10.1016/j.bbrc.2007.06.095. PubMed DOI

Piskacek M, Havelka M, Rezacova M, Knight A. The 9aaTAD is exclusive activation domain in Gal4. PLoS One. 2017;12:e0169261. doi: 10.1371/journal.pone.0169261. PubMed DOI PMC

Kakidani H, Ptashne M. GAL4 activates gene expression in mammalian cells. Cell. 1988;52:161–167. doi: 10.1016/0092-8674(88)90504-1. PubMed DOI

Fields S, Jang SK. Presence of a potent transcription activating sequence in the p53 protein. Science. 1990;249:1046–1049. doi: 10.1126/science.2144363. PubMed DOI

Piskacek M, Havelka M, Jendruchova K, Knight A. Nuclear hormone receptors: ancient 9aaTAD and evolutionally gained NCoA activation pathways. J Steroid Biochem Mol Biol. 2018 doi: 10.1016/j.jsbmb.2018.11.008. PubMed DOI

Triezenberg SJ. Structure and function of transcriptional activation domains. Curr Opin Genet Dev. 1995;5:190–196. doi: 10.1016/0959-437X(95)80007-7. PubMed DOI

Ma J, Ptashne M. A new class of yeast transcriptional activators. Cell. 1987;51:113–119. doi: 10.1016/0092-8674(87)90015-8. PubMed DOI

Courey AJ, Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 1988;55:887–898. doi: 10.1016/0092-8674(88)90144-4. PubMed DOI

Courey AJ, Holtzman DA, Jackson SP, Tjian R. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell. 1989;59:827–836. doi: 10.1016/0092-8674(89)90606-5. PubMed DOI

Tanese N, Pugh BF, Tjian R. Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. Genes Dev. 1991;5:2212–2224. doi: 10.1101/gad.5.12a.2212. PubMed DOI

Mermod N, O’Neill EA, Kelly TJ, Tjian R. The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell. 1989;58:741–753. doi: 10.1016/0092-8674(89)90108-6. PubMed DOI

Stargell LA, Struhl K. The TBP-TFIIA interaction in the response to acidic activators in vivo. Science. 1995;269:75–78. doi: 10.1126/science.7604282. PubMed DOI

Chou S, Struhl K. Transcriptional activation by TFIIB mutants that are severely impaired in interaction with promoter DNA and acidic activation domains. Mol Cell Biol. 1997;17:6794–6802. doi: 10.1128/MCB.17.12.6794. PubMed DOI PMC

Dorris DR, Struhl K. Artificial recruitment of TFIID, but not RNA polymerase II holoenzyme, activates transcription in mammalian cells. Mol Cell Biol. 2000;20:4350–4358. doi: 10.1128/MCB.20.12.4350-4358.2000. PubMed DOI PMC

Thoden JB, Ryan LA, Reece RJ, Holden HM. The interaction between an acidic transcriptional activator and its inhibitor. The molecular basis of Gal4p recognition by Gal80p. J Biol Chem. 2008;283:30266–30272. doi: 10.1074/jbc.M805200200. PubMed DOI PMC

Drysdale CM, Dueñas E, Jackson BM, et al. The transcriptional activator GCN4 contains multiple activation domains that are critically dependent on hydrophobic amino acids. Mol Cell Biol. 1995;15:1220–1233. doi: 10.1128/MCB.15.3.1220. PubMed DOI PMC

Jackson BM, Drysdale CM, Natarajan K, Hinnebusch AG. Identification of seven hydrophobic clusters in GCN4 making redundant contributions to transcriptional activation. Mol Cell Biol. 1996;16:5557–5571. doi: 10.1128/MCB.16.10.5557. PubMed DOI PMC

Natarajan K, Meyer MR, Jackson BM, et al. Transcriptional profiling shows that Gcn4p is a master regulator of gene expression during amino acid starvation in yeast. Mol Cell Biol. 2001;21:4347–4368. doi: 10.1128/MCB.21.13.4347-4368.2001. PubMed DOI PMC

Jedidi I, Zhang F, Qiu H, et al. Activator Gcn4 employs multiple segments of Med15/Gal11, including the KIX domain, to recruit mediator to target genes in vivo. J Biol Chem. 2010;285:2438–2455. doi: 10.1074/jbc.M109.071589. PubMed DOI PMC

Krois AS, Ferreon JC, Martinez-Yamout MA, et al. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein. Proc Natl Acad Sci USA. 2016;113:E1853–1862. doi: 10.1073/pnas.1602487113. PubMed DOI PMC

Lee CW, Arai M, Martinez-Yamout MA, et al. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. Biochemistry. 2009;48:2115–2124. doi: 10.1021/bi802055v. PubMed DOI PMC

Denis CM, Chitayat S, Plevin MJ, et al. Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1. Blood. 2012 doi: 10.1182/blood-2012-02-411397. PubMed DOI

Wang F, Marshall CB, Li G-Y, et al. Synergistic interplay between promoter recognition and CBP/p300 coactivator recruitment by FOXO3a. ACS Chem Biol. 2009;4:1017–1027. doi: 10.1021/cb900190u. PubMed DOI

Radhakrishnan I, Pérez-Alvarado GC, Parker D, et al. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell. 1997;91:741–752. doi: 10.1016/S0092-8674(00)80463-8. PubMed DOI

Lee CW, Martinez-Yamout MA, Dyson HJ, Wright PE. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein. Biochemistry. 2010;49:9964–9971. doi: 10.1021/bi1012996. PubMed DOI PMC

Wojciak JM, Martinez-Yamout MA, Dyson HJ, Wright PE. Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains. EMBO J. 2009;28:948–958. doi: 10.1038/emboj.2009.30. PubMed DOI PMC

Gill G, Pascal E, Tseng ZH, Tjian R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci USA. 1994;91:192–196. doi: 10.1073/pnas.91.1.192. PubMed DOI PMC

Titz B, Thomas S, Rajagopala SV, et al. Transcriptional activators in yeast. Nucleic Acids Res. 2006;34:955–967. doi: 10.1093/nar/gkj493. PubMed DOI PMC

Escher D, Bodmer-Glavas M, Barberis A, Schaffner W. Conservation of glutamine-rich transactivation function between yeast and humans. Mol Cell Biol. 2000;20:2774–2782. doi: 10.1128/MCB.20.8.2774-2782.2000. PubMed DOI PMC

Hahn S. Structure(?) and function of acidic transcription activators. Cell. 1993;72:481–483. doi: 10.1016/0092-8674(93)90064-W. PubMed DOI

Brzovic PS, Heikaus CC, Kisselev L, et al. The acidic transcription activator Gcn4 binds the mediator subunit Gal11/Med15 using a simple protein interface forming a fuzzy complex. Mol Cell. 2011;44:942–953. doi: 10.1016/j.molcel.2011.11.008. PubMed DOI PMC

Lu Z, Ansari AZ, Lu X, et al. A target essential for the activity of a nonacidic yeast transcriptional activator. Proc Natl Acad Sci USA. 2002;99:8591–8596. doi: 10.1073/pnas.092263499. PubMed DOI PMC

Ma J, Ptashne M. Deletion analysis of GAL4 defines two transcriptional activating segments. Cell. 1987;48:847–853. doi: 10.1016/0092-8674(87)90081-X. PubMed DOI

Ferreira ME, Hermann S, Prochasson P, et al. Mechanism of transcription factor recruitment by acidic activators. J Biol Chem. 2005;280:21779–21784. doi: 10.1074/jbc.M502627200. PubMed DOI

Staller MV, Holehouse AS, Swain-Lenz D, et al. A high-throughput mutational scan of an intrinsically disordered acidic transcriptional activation domain. Cell Syst. 2018 doi: 10.1016/j.cels.2018.01.015. PubMed DOI PMC

Zhang H-M, Liu T, Liu C-J, et al. AnimalTFDB 2.0: a resource for expression, prediction and functional study of animal transcription factors. Nucleic Acids Res. 2015;43:D76–81. doi: 10.1093/nar/gku887. PubMed DOI PMC

Kolell KJ, Crawford DL. Evolution of Sp transcription factors. Mol Biol Evol. 2002;19:216–222. doi: 10.1093/oxfordjournals.molbev.a004074. PubMed DOI

Kaczynski J, Cook T, Urrutia R. Sp1- and Krüppel-like transcription factors. Genome Biol. 2003;4:206. doi: 10.1186/gb-2003-4-2-206. PubMed DOI PMC

Suske G, Bruford E, Philipsen S. Mammalian SP/KLF transcription factors: bring in the family. Genomics. 2005;85:551–556. doi: 10.1016/j.ygeno.2005.01.005. PubMed DOI

Vizcaíno C, Mansilla S, Portugal J. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther. 2015;152:111–124. doi: 10.1016/j.pharmthera.2015.05.008. PubMed DOI

Mir R, Sharma A, Pradhan SJ, Galande S. Regulation of transcription factor SP1 by β-catenin destruction complex modulates Wnt response. bioRxiv 308841. 2018 doi: 10.1101/308841. PubMed DOI PMC

Rane MJ, Zhao Y, Cai L. Krϋppel-like factors (KLFs) in renal physiology and disease. EBioMedicine. 2019 doi: 10.1016/j.ebiom.2019.01.021. PubMed DOI PMC

Miller JH. Experiments in molecular genetics. New York: Cold Spring Harbor Laboratory; 1972.

Baumgartner U, Hamilton B, Piskacek M, et al. Functional analysis of the Zn(2)Cys(6) transcription factors Oaf1p and Pip2p. Different roles in fatty acid induction of beta-oxidation in Saccharomyces cerevisiae. J Biol Chem. 1999;274:22208–22216. doi: 10.1074/jbc.274.32.22208. PubMed DOI

Leuther KK, Salmeron JM, Johnston SA. Genetic evidence that an activation domain of GAL4 does not require acidity and may form a beta sheet. Cell. 1993;72:575–585. doi: 10.1016/0092-8674(93)90076-3. PubMed DOI

Baur F, Nau K, Sadic D, et al. Specificity protein 2 (Sp2) is essential for mouse development and autonomous proliferation of mouse embryonic fibroblasts. PLoS One. 2010;5:e9587. doi: 10.1371/journal.pone.0009587. PubMed DOI PMC

Terrados G, Finkernagel F, Stielow B, et al. Genome-wide localization and expression profiling establish Sp2 as a sequence-specific transcription factor regulating vitally important genes. Nucleic Acids Res. 2012;40:7844–7857. doi: 10.1093/nar/gks544. PubMed DOI PMC

Völkel S, Stielow B, Finkernagel F, et al. Zinc finger independent genome-wide binding of Sp2 potentiates recruitment of histone-fold protein Nf-y distinguishing it from Sp1 and Sp3. PLoS Genet. 2015;11:e1005102. doi: 10.1371/journal.pgen.1005102. PubMed DOI PMC

Ratajewski M, Walczak-Drzewiecka A, Gorzkiewicz M, et al. Expression of human gene coding RORγT receptor depends on the Sp2 transcription factor. J Leukoc Biol. 2016;100:1213–1223. doi: 10.1189/jlb.6A0515-212RR. PubMed DOI

Zschemisch N-H, Brüsch I, Hambusch A-S, Bleich A. Transcription factor SP2 enhanced the expression of Cd14 in colitis-susceptible C3H/HeJBir. PLoS One. 2016;11:e0155821. doi: 10.1371/journal.pone.0155821. PubMed DOI PMC

Moorefield KS, Fry SJ, Horowitz JM. Sp2 DNA binding activity and trans-activation are negatively regulated in mammalian cells. J Biol Chem. 2004;279:13911–13924. doi: 10.1074/jbc.M313589200. PubMed DOI

Yin H, Nichols TD, Horowitz JM. Transcription of mouse Sp2 yields alternatively spliced and sub-genomic mRNAs in a tissue- and cell-type-specific fashion. Biochim Biophys Acta. 2010;1799:520–531. doi: 10.1016/j.bbagrm.2010.03.002. PubMed DOI PMC

Phan D, Cheng C-J, Galfione M, et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004;64:3072–3078. doi: 10.1158/0008-5472.CAN-03-3730. PubMed DOI

Yesudhas D, Anwar MA, Panneerselvam S, et al. Evaluation of Sox2 binding affinities for distinct DNA patterns using steered molecular dynamics simulation. FEBS Open Bio. 2017;7:1750–1767. doi: 10.1002/2211-5463.12316. PubMed DOI PMC

Kamachi Y, Kondoh H. Sox proteins: regulators of cell fate specification and differentiation. Development. 2013;140:4129–4144. doi: 10.1242/dev.091793. PubMed DOI

Lodato MA, Ng CW, Wamstad JA, et al. SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state. PLoS Genet. 2013;9:e1003288. doi: 10.1371/journal.pgen.1003288. PubMed DOI PMC

Ward SV, Samuel CE. The pkr kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins. Virology. 2003;313:553–566. doi: 10.1016/S0042-6822(03)00347-7. PubMed DOI

Jaiswal AS, Balusu R, Narayan S. 7,12-Dimethylbenzanthracene-dependent transcriptional regulation of adenomatous polyposis coli (APC) gene expression in normal breast epithelial cells is mediated by GC-box binding protein Sp3. Carcinogenesis. 2006;27:252–261. doi: 10.1093/carcin/bgi225. PubMed DOI

Li L, Davie JR. The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat Anatomischer Anz. 2010;192:275–283. doi: 10.1016/j.aanat.2010.07.010. PubMed DOI

Erwin DH, Laflamme M, Tweedt SM, et al. The Cambrian conundrum: early divergence and later ecological success in the early history of animals. Science. 2011;334:1091–1097. doi: 10.1126/science.1206375. PubMed DOI

Presnell JS, Schnitzler CE, Browne WE. KLF/SP transcription factor family evolution: expansion, diversification, and innovation in eukaryotes. Genome Biol Evol. 2015;7:2289–2309. doi: 10.1093/gbe/evv141. PubMed DOI PMC

Hackett SJ, Kimball RT, Reddy S, et al. A phylogenomic study of birds reveals their evolutionary history. Science. 2008;320:1763–1768. doi: 10.1126/science.1157704. PubMed DOI

Christoffels A, Koh EGL, Chia J-M, et al. Fugu genome analysis provides evidence for a whole-genome duplication early during the evolution of ray-finned fishes. Mol Biol Evol. 2004;21:1146–1151. doi: 10.1093/molbev/msh114. PubMed DOI

Conkright MD, Wani MA, Lingrel JB. Lung Krüppel-like factor contains an autoinhibitory domain that regulates its transcriptional activation by binding WWP1, an E3 ubiquitin ligase. J Biol Chem. 2001;276:29299–29306. doi: 10.1074/jbc.M103670200. PubMed DOI

Geiman DE, Ton-That H, Johnson JM, Yang VW. Transactivation and growth suppression by the gut-enriched Krüppel-like factor (Krüppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res. 2000;28:1106–1113. doi: 10.1093/nar/28.5.1106. PubMed DOI PMC

Mas C, Lussier-Price M, Soni S, et al. Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF) Proc Natl Acad Sci USA. 2011;108:10484–10489. doi: 10.1073/pnas.1017029108. PubMed DOI PMC

Knights AJ, Yik JJ, Mat Jusoh H, et al. Krüppel-like factor 3 (KLF3/BKLF) is required for widespread repression of the inflammatory modulator Galectin-3 (Lgals3) J Biol Chem. 2016;291:16048–16058. doi: 10.1074/jbc.M116.715748. PubMed DOI PMC

Klein RH, Hu W, Kashgari G, et al. Characterization of enhancers and the role of the transcription factor KLF7 in regulating corneal epithelial differentiation. J Biol Chem. 2017;292:18937–18950. doi: 10.1074/jbc.M117.793117. PubMed DOI PMC

Das A, Fernandez-Zapico ME, Cao S, et al. Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J Biol Chem. 2006;281:39105–39113. doi: 10.1074/jbc.M607720200. PubMed DOI

Zhang H, Zhu X, Chen J, et al. Krüppel-like factor 12 is a novel negative regulator of forkhead box O1 expression: a potential role in impaired decidualization. Reprod Biol Endocrinol. 2015;13:80. doi: 10.1186/s12958-015-0079-z. PubMed DOI PMC

Pace CN, Scholtz JM. A helix propensity scale based on experimental studies of peptides and proteins. Biophys J. 1998;75:422–427. doi: 10.1016/S0006-3495(98)77529-0. PubMed DOI PMC

Pacheco D, Warfield L, Brajcich M, et al. Transcription activation domains of the yeast factors Met4 and Ino2: tandem activation domains with properties similar to the yeast Gcn4 activator. Mol Cell Biol. 2018 doi: 10.1128/MCB.00038-18. PubMed DOI PMC

Warfield L, Tuttle LM, Pacheco D, et al. A sequence-specific transcription activator motif and powerful synthetic variants that bind Mediator using a fuzzy protein interface. Proc Natl Acad Sci USA. 2014;111:E3506–3513. doi: 10.1073/pnas.1412088111. PubMed DOI PMC

Carbone L, Harris RA, Gnerre S, et al. Gibbon genome and the fast karyotype evolution of small apes. Nature. 2014;513:195–201. doi: 10.1038/nature13679. PubMed DOI PMC

Chong S, Dugast-Darzacq C, Liu Z, et al. Imaging dynamic and selective low-complexity domain interactions that control gene transcription. Science. 2018 doi: 10.1126/science.aar2555. PubMed DOI PMC

Myc 9aaTAD activation domain binds to mediator of transcription with superior high affinity

The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4